El grupo Neurodegeneración corneal del IDIS descubre biomarcadores en lágrima claves para detectar precozmente el queratocono en hijos de pacientes afectados

El grupo Neurodegeneración corneal del IDIS descubre biomarcadores en lágrima claves para detectar precozmente el queratocono en hijos de pacientes afectados

El estudio realizado por la Dra. Isabel Lema y su equipo ha sido publicado por IOVS – Investigative Ophtalmology & Visual Science, principal revista en oftalmología Santiago de Compostela, 2 de junio de 2025.- Un equipo de investigadoras del grupo...
The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, receives the XXIII Nóvoa Santos Award

The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, receives the XXIII Nóvoa Santos Award

On April 26, 2024, Santiago de Compostela.- The scientific director of the Health Research Institute of Santiago de Compostela (IDIS), Mª Luz Couce Pico, was honored with the XXIII Nóvoa Santos Award by the association AMG (Association of Galician Doctors). The award...
DIVERSA Biotechnologies has concluded its capital expansion with Sémola Tech Ventures SL, Volsunga SL, Janus Projects SL, and UNIRISCO.

DIVERSA Biotechnologies has concluded its capital expansion with Sémola Tech Ventures SL, Volsunga SL, Janus Projects SL, and UNIRISCO.

Santiago de Compostela, April 24, 2024.- DIVERSA Technologies SL, a company aiming to make an impact across the entire value chain in the field of biotechnology and nanomedicine, closed its capital expansion. Their focus is on driving the development of innovative...